Literature DB >> 23873081

DNA targeting specificity of RNA-guided Cas9 nucleases.

Patrick D Hsu1, David A Scott, Joshua A Weinstein, F Ann Ran, Silvana Konermann, Vineeta Agarwala, Yinqing Li, Eli J Fine, Xuebing Wu, Ophir Shalem, Thomas J Cradick, Luciano A Marraffini, Gang Bao, Feng Zhang.   

Abstract

The Streptococcus pyogenes Cas9 (SpCas9) nuclease can be efficiently targeted to genomic loci by means of single-guide RNAs (sgRNAs) to enable genome editing. Here, we characterize SpCas9 targeting specificity in human cells to inform the selection of target sites and avoid off-target effects. Our study evaluates >700 guide RNA variants and SpCas9-induced indel mutation levels at >100 predicted genomic off-target loci in 293T and 293FT cells. We find that SpCas9 tolerates mismatches between guide RNA and target DNA at different positions in a sequence-dependent manner, sensitive to the number, position and distribution of mismatches. We also show that SpCas9-mediated cleavage is unaffected by DNA methylation and that the dosage of SpCas9 and sgRNA can be titrated to minimize off-target modification. To facilitate mammalian genome engineering applications, we provide a web-based software tool to guide the selection and validation of target sequences as well as off-target analyses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23873081      PMCID: PMC3969858          DOI: 10.1038/nbt.2647

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  28 in total

1.  Chimeric nucleases stimulate gene targeting in human cells.

Authors:  Matthew H Porteus; David Baltimore
Journal:  Science       Date:  2003-05-02       Impact factor: 47.728

2.  Targeting DNA double-strand breaks with TAL effector nucleases.

Authors:  Michelle Christian; Tomas Cermak; Erin L Doyle; Clarice Schmidt; Feng Zhang; Aaron Hummel; Adam J Bogdanove; Daniel F Voytas
Journal:  Genetics       Date:  2010-07-26       Impact factor: 4.562

3.  A rapid and general assay for monitoring endogenous gene modification.

Authors:  Dmitry Y Guschin; Adam J Waite; George E Katibah; Jeffrey C Miller; Michael C Holmes; Edward J Rebar
Journal:  Methods Mol Biol       Date:  2010

4.  Targeted genome editing in pluripotent stem cells using zinc-finger nucleases.

Authors:  Sylwia Bobis-Wozowicz; Anna Osiak; Shamim H Rahman; Toni Cathomen
Journal:  Methods       Date:  2010-12-23       Impact factor: 3.608

5.  An improved zinc-finger nuclease architecture for highly specific genome editing.

Authors:  Jeffrey C Miller; Michael C Holmes; Jianbin Wang; Dmitry Y Guschin; Ya-Li Lee; Igor Rupniewski; Christian M Beausejour; Adam J Waite; Nathaniel S Wang; Kenneth A Kim; Philip D Gregory; Carl O Pabo; Edward J Rebar
Journal:  Nat Biotechnol       Date:  2007-07-01       Impact factor: 54.908

6.  De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks.

Authors:  Magdy M Mahfouz; Lixin Li; Md Shamimuzzaman; Anjar Wibowo; Xiaoyun Fang; Jian-Kang Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

7.  A TALE nuclease architecture for efficient genome editing.

Authors:  Jeffrey C Miller; Siyuan Tan; Guijuan Qiao; Kyle A Barlow; Jianbin Wang; Danny F Xia; Xiangdong Meng; David E Paschon; Elo Leung; Sarah J Hinkley; Gladys P Dulay; Kevin L Hua; Irina Ankoudinova; Gregory J Cost; Fyodor D Urnov; H Steve Zhang; Michael C Holmes; Lei Zhang; Philip D Gregory; Edward J Rebar
Journal:  Nat Biotechnol       Date:  2010-12-22       Impact factor: 54.908

8.  Nucleotide sequences in Xenopus 5S DNA required for transcription termination.

Authors:  D F Bogenhagen; D D Brown
Journal:  Cell       Date:  1981-04       Impact factor: 41.582

9.  Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA).

Authors:  Jeffry D Sander; Elizabeth J Dahlborg; Mathew J Goodwin; Lindsay Cade; Feng Zhang; Daniel Cifuentes; Shaun J Curtin; Jessica S Blackburn; Stacey Thibodeau-Beganny; Yiping Qi; Christopher J Pierick; Ellen Hoffman; Morgan L Maeder; Cyd Khayter; Deepak Reyon; Drena Dobbs; David M Langenau; Robert M Stupar; Antonio J Giraldez; Daniel F Voytas; Randall T Peterson; Jing-Ruey J Yeh; J Keith Joung
Journal:  Nat Methods       Date:  2010-12-12       Impact factor: 28.547

10.  CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.

Authors:  Elitza Deltcheva; Krzysztof Chylinski; Cynthia M Sharma; Karine Gonzales; Yanjie Chao; Zaid A Pirzada; Maria R Eckert; Jörg Vogel; Emmanuelle Charpentier
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

View more
  1799 in total

Review 1.  Human Germline Genome Editing.

Authors:  Kelly E Ormond; Douglas P Mortlock; Derek T Scholes; Yvonne Bombard; Lawrence C Brody; W Andrew Faucett; Nanibaa' A Garrison; Laura Hercher; Rosario Isasi; Anna Middleton; Kiran Musunuru; Daniel Shriner; Alice Virani; Caroline E Young
Journal:  Am J Hum Genet       Date:  2017-08-03       Impact factor: 11.025

2.  Landscape of target:guide homology effects on Cas9-mediated cleavage.

Authors:  Becky Xu Hua Fu; Loren L Hansen; Karen L Artiles; Michael L Nonet; Andrew Z Fire
Journal:  Nucleic Acids Res       Date:  2014-11-15       Impact factor: 16.971

3.  Protein engineering of Cas9 for enhanced function.

Authors:  Benjamin L Oakes; Dana C Nadler; David F Savage
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

4.  The iCRISPR platform for rapid genome editing in human pluripotent stem cells.

Authors:  Zengrong Zhu; Federico González; Danwei Huangfu
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

Review 5.  Determining the specificities of TALENs, Cas9, and other genome-editing enzymes.

Authors:  Vikram Pattanayak; John P Guilinger; David R Liu
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

6.  Creating cancer translocations in human cells using Cas9 DSBs and nCas9 paired nicks.

Authors:  Benjamin Renouf; Marion Piganeau; Hind Ghezraoui; Maria Jasin; Erika Brunet
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

7.  Disrupted apical exocytosis of cargo vesicles causes enteropathy in FHL5 patients with Munc18-2 mutations.

Authors:  Georg F Vogel; Jorik M van Rijn; Iris M Krainer; Andreas R Janecke; Carsten Posovszky; Marta Cohen; Claire Searle; Prevost Jantchou; Johanna C Escher; Natalie Patey; Ernest Cutz; Thomas Müller; Sabine Middendorp; Michael W Hess; Lukas A Huber
Journal:  JCI Insight       Date:  2017-07-20

Review 8.  Exploiting CRISPR/Cas systems for biotechnology.

Authors:  Timothy R Sampson; David S Weiss
Journal:  Bioessays       Date:  2014-01       Impact factor: 4.345

Review 9.  CRISPR-Cas systems for editing, regulating and targeting genomes.

Authors:  Jeffry D Sander; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-03-02       Impact factor: 54.908

10.  Thyroid hormone receptor beta and NCOA4 regulate terminal erythrocyte differentiation.

Authors:  Xiaofei Gao; Hsiang-Ying Lee; Wenbo Li; Randall Jeffrey Platt; M Inmaculada Barrasa; Qi Ma; Russell R Elmes; Michael G Rosenfeld; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.